AGH
Director Trades
| Date | Director | Value |
|---|---|---|
| 31/10/24 | V. Webber | $44,486 |
| 28/4/25 | M. Adams | $20,000 |
| 28/4/25 | V. Webber | $20,000 |
| 28/4/25 | J. Fegan | $80,000 |
Company News
Drawbacks of the TGA’s cannabis changes for listed pot stocks
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than they […]
Althea begins online medicinal cannabis sales supported by telemedicine
Two weeks since securing a new patient referral agreement and approvals for more clinic locations, medicinal cannabis company Althea Group (ASX: AGH) has turned its attentions to making commercial progress online. In a statement this morning, Althea said it will begin online sales of medicinal cannabis from its Althea Concierge platform, including delivery in what the […]
Althea’s MyAccess Clinics boosts UK expansion, teams up with Drug Science
Pharma company Althea Group (ASX: AGH) has unveiled a string of advances in the UK citing “significant progress” in securing a new patient referral agreement, further approvals for more clinic locations and an agreement with an independent scientific committee. With respect to the UK, the company indicated it is making incremental progress and ultimately seeks to […]
Althea gets set for German market expansion after executing supply agreement with Nimbus Health
Pharmaceutical company Althea Group (ASX: AGH) has added Germany to its list of active markets following the signing of a three-year supply and distribution agreement with wholesaler Nimbus Health. Althea will now see its products sold in Australia, the UK, Canada and Germany as part of a sequential global expansion strategy. Nimbus is a German […]
Althea Group bags record revenues as medicinal cannabis sales continue growing worldwide
Pharmaceutical company Althea Group (ASX: AGH) has published an interim update regarding its active businesses in Australia, Canada and the UK, declaring that February bettered January as the company’s second-best month on record. The company expects to record the highest revenue month in its history this month as demand for medicinal cannabis continues to grow […]
Althea continues medicinal cannabis industry expansion mission in Europe
Althea Group (ASX: AGH) continues to make inroads into the European market with operations in both the UK and Germany now online, supported by its proprietary technology platform Althea Concierge. The medicinal cannabis company is also making commercial progress closer to home in Australia with over 3,000 patients now on its books, almost 500 of which […]
Althea grows local market presence after teaming up with medicinal cannabis distributer
Medicinal cannabis company Althea Group (ASX: AGH) has inked a product supply and distribution agreement with Cannvalate which is expected to underpin further rapid sales growth in Australia. According to Althea, Melbourne-based Cannvalate boasts Australia’s largest network of medicinal cannabis prescribing clinics spanning all states. Under the agreement, Cannvalate will become a non-exclusive distributor of […]
Althea expands its medicinal cannabis offering into the UK
Althea (ASX: AGH) is set to become one of the first medicinal cannabis companies to enter the United Kingdom after announcing the acquisition of subsidiary Althea UK. The purchase, of which the value was not disclosed, will enable Althea to extend its patient acquisition model into the UK which has an estimated 2.9 million treatable […]
Althea continues global growth spurt with first UK prescription and green light for Australian manufacturing facility
Medicinal cannabis company Althea Group (ASX: AGH) has found UK market traction after its British subsidiary, Althea MMJ UK, received the first patient prescription for its proprietary medicinal cannabis product. The ASX-listed company will now be tasked with supplying its first UK-based patients, a feat that is considered both commercially positive and a testament to the […]
Althea receives green-light to cultivate hemp, teams up with Tissue Culture Australia
Agriculture Victoria has given Althea Group Holdings (ASX: AGH) the green light to cultivate hemp in the state, while Tissue Culture Australia has agreed to assist Althea in developing tissue cultures for its proposed growing facility. The hemp cultivation licence now enables Althea to grow and process low-THC hemp plants, which the company plans to […]